关键词: 良性肿瘤, 麦默通, 乳腺

Abstract: Objective To explore the safety and clinical efficacy of vacuum assisted system in the treatment of benign breast tumors. Methods From January 2017 to January 2020, 200 cases of breast diseasein Guangzhou Zengcheng District People′s Hospital were selected, whose everage age was （39.23±13.02） years. They were assigned to the Mammotome group （115 cases） and the open operation group （85 cases）, The operative time, pain, bleeding volume, postoperative hematoma/serum swelling and infection were compared between the two groups. The patients were followed up for 6 months and 1 year after operation. Results The operative time, blood loss, recovery time and postoperative hematoma/serum swelling and infection in the Mammotome group were all lower than those in the open group. The difference was statistically significant （P<0.05）. The satisfaction of the mermetone group （99.12%） was higher than that in the open group （84.34%,P<0.05）. Follow-up showed that there was no significant difference between the recurrence rate （4.39%） and the open operation group （8.43%, P>0.05%）. Conclusion The minimally invasive Mammotome system, compared with traditional surgery, can reduce the operation time, wound healing time, analgesic dosage and complications,which is conducived to the recovery of patients.

Key words: benign tumor, Mammotome, breast